Braddy, I covered my short this AM @ 113 ¼ for a 0.5 point < GG >short term profit.
Not as much as I had hoped for; people still seem mesmerized by the $$$ signs in front of Viagra and are holding on to the stock, gg.
Not to worry however, just getting warmed up here, GG.
Can't wait for the Celebrex pop to get back in:
"But detailed clinical data on Celebrex has not yet been published, and some
researchers still have concerns about COX-2 drugs. "I will predict these won't
be safer in patients with intrinsic kidney disease," Harvard's Simon said. "https://www.siliconinvestor.com/readmsg.aspx?msgid=6586650
<< GGG >>
Well, well, well,……….what do we have here,
" detailed clinical data on Celebrex has not yet been published ".
Reeally ?
Kidney side effects? Other? Side effects?
And more,
"With treatment expected to cost $2-$4 a day, Zisson thinks first year sales may
hit $300-400 million, but final estimates will depend on whether health insurers
decide on strict limits for who gets the new drugs, according to Zisson."
Another expensive drug? Another Viagra in the making? GG
Prostaglandins are the body's natural vasodilators. Celebrex by inhibiting them will cause a generalized circulatory vasoconstriction and cut perfusion to vital organs. NSAIDs already do this and knock the kidney for a loop. ( Over the counter non-steroidals have been a boon to nephrologists ).
I am ready Braddy to short PFE again on it's next move up, GG. Of course if the FDA puts the brakes on Celebrex this week we'll immediately short just as fast as on it's way up,
Tuna,
a hard working doc just trying to make a couple of extra bucks
|
